Theradaptive, a Maryland-based, privately held, clinical-stage biologics company, today announced the initiation of patient dosing in Maryland for the ongoing OASIS Phase I/II clinical trial assessing ...

SurGenTec asserts that the OsteoFlo HydroFiber may improve patient outcomes versus the use of allograft/autograft in spinal ...

A list of my favorite non-alcoholic beers and hop waters, all of which are currently available in metro Denver ...

Medical implants are gaining in importance for patient quality of life. Advancements in additive manufacturing processes, otherwise known as 3D printing, and the development of compatible tantalum and ...

Nevro NVRO is well-poised for growth in the coming quarters, courtesy of its business expansion plans and restructuring activities. The optimism, led by a decent preliminary full-year 2024 results, is ...

SurGenTec® Breaks New Ground with FDA Clearance for OsteoFlo® HydroFiber™, Receives Indication for Stand-Alone Use Equivalent to Autograft ...

ASC leaders are optimistic about the future, citing opportunities for growth over the next five years, including the migration of cardiology procedures to ASCs and increasing patient interest.

Recently, Dr. J. Alex Sielatycki, a fellowship-trained spine surgeon at Pioneers Medical Center (PMC) in Meeker, started ...

This phenomenon may occur in ankylosing spondylitis and describes the "fusing" or growing together of the "vertebrae," which are the bones in your spine. The fusion is caused by ... spondylitis and ...

Equities researchers at Zacks Research raised their Q2 2025 earnings per share estimates for shares of Globus Medical in a research note issued on Tuesday, January 21st. Zacks Research analyst R.